Companies Investors People

Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing

Resources

Documentation
CLI
MCP
Feature Requests
Sitemap

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy · Terms of Service · Privacy FAQ

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading

Atrandi Biosciences

Atrandi Biosciences

Atrandi Biosciences builds instruments and kits for high-throughput single-cell analysis using semi-permeable capsules and droplet microfluidics.

Operating headquarters

Vilnius, LT🇱🇹

Founded

Atrandi Biosciences develops tools for single-cell analysis. Its semi-permeable capsule technology enables researchers to isolate cells while exchanging reagents for multi-step workflows and multi-omic assays.

The company sells microfluidic instruments, application kits and consumables for capsule generation, high-throughput screening and single-cell genomics. Its tools support laboratory workflows that combine droplet microfluidics with repeated reagent exchange.

Atrandi Biosciences - Similar Companies

Parallel Fluidics

Rebus Biosystems

rebusbio.com

S2 Genomics

s2genomics.com

Partillion Bioscience

partillion.com

10x Genomics

10xgenomics.com

Fluent BioSciences

fluentbio.com

CellDrop Biosciences

celldrop.co

Parse Biosciences

CytoRecovery

cytorecovery.com

CytoMag

Volta Labs

voltalabs.com

Spatial Genomics

Carterra

carterra-bio.com

Celldom

celldom.com

Transition Bio

transitionbio.com

Atrandi Biosciences - Quick Facts

Who are Atrandi Biosciences' competitors?

Companies similar to Atrandi Biosciences include Parallel Fluidics, Rebus Biosystems, S2 Genomics and Partillion Bioscience.

When was Atrandi Biosciences founded?

Atrandi Biosciences was founded in 2016.

Where is Atrandi Biosciences' headquarters located?

Atrandi Biosciences' headquarters is located in Vilnius, LT.

When was Atrandi Biosciences' last funding round?

Atrandi Biosciences' most recent funding round was for $25M (USD) in February 2025.

How much has Atrandi Biosciences raised to-date?

As of Feb 19, 2025, Atrandi Biosciences has raised a total of $25M (USD).

Atrandi Biosciences - Classification

Industry: Biotechnology
Technology: Microfluidics

Tags: Lab Automation